Institute of Oncology

< Back

The Institute of Oncology was established on 1 July 2011 by a resolution of the Senate of the Lithuanian University of Health Sciences of 15 April 2011. The Institute of Oncology of the Faculty of Medicine under the Medical Academy of the Lithuanian University of Health Sciences is a structural unit of the organisation of research activities that does not hold the status of a legal person. The Institute of Oncology conducts scientific research and experimental development activities of strategic importance to the University, delivers courses under the respective study programmes, and trains prospective researchers.

The Institute of Oncology consists of the departments of the faculty: the Oncology and Hematology Clinic and the Oncology Research Laboratory.

Studies

The staff of the Institute of Oncology teach the students of integrated study programme “Medicine” (in Lithuanian and English), undergraduate students of the study programmes “Medical and Veterinary Genetics”, graduate students of “Laboratory Medicine Biology”, and act as supervisors to the residents. The Institute provides guidance to the undergraduate students of “Medical and Veterinary Biochemistry”, students of integrated study programme “Medicine”(to the Lithuanian and international students). The staff of the Institute of Oncology teach 4 doctoral courses: “Biology of tumours, new diagnostic and treatment methods, biological therapy”, “Prognostic and predictive genetic actions of tumours of different localisations”, “Oncology”, “Thrombophilias and haemorrhagic dialysis”.

The Institute of Oncology employs 20 teachers: 3 professors, 3 associate professors, 11 lecturers, and 3 assistants. The Laboratory of Oncology Research of the Institute of Oncology employs 1 senior researcher, and 5 junior researchers.

Research

Research topics at the Institute of Oncology:

  • The role of non-coding RNAs of the small protein in breast cancer pathogenesis and the effect of non-steroidal anti-inflammatory drugs (NSADs) on their expression. Head of the research topic: Prof. Elona Juozaitytė
  • Evaluation of the efficacy of a combination of electroporation and immunotherapy and their different regimens in the treatment of melanoma in an in vivo mouse model. Head of the research topic: Prof. Dr. Rasa Jančiauskienė
  • Impact of DNA damage repair system genes on the prognosis and treatment personalisation in high-risk ovarian cancer patients. Head of the research topic: Assoc. Prof. Dr. Sigita Liutkauskienė
  • Exploration of the genetic factors influencing the course of cervical cancer. Head of the research topic: Prof. Arturas Inčiūra
  • Evaluation of the outcome and clinical and molecular markers of locally advanced rectal cancer after preoperative chemoradiation or systemic therapy. Head of the research topic: Prof. Rasa Jančiauskienė
  • The role of calreticulin in the pathogenesis of myeloproliferative diseases. Head of the research topic: Prof. Rasa Ugenskienė / consultant Prof. Elona Juozaitytė
  • Molecular mechanisms of sensitivity and resistance of breast cancer cells to radiotherapy. Head of the research topic: Prof. Arturas Inčiūra
  • The study of the prognostic value of complete pathological response in breast cancer after neoadjuvant systemic therapy. Head of the research topic: Lect. Jurgita Gudaitienė
  • Investigating the characteristics of neuroendocrine tumours. Head of the research topic: Prof. Rasa Jančiauskienė
  • Diagnostic and therapeutic features of cancer cachexia. Head of the research topic: Lect. Dalia Skorupskienė
  • Efficacy of the JAK2 inhibitors in the treatment of myelofibrosis. Head of the research topic: Assoc. Prof. Rolandas Gerbutavičius
  • Tandem autologous stem cell transplantation for the treatment of myeloma. Head of the research topic: Assoc. Prof. Rolandas Gerbutavičius
  • miR-200a and miR-200b associations with the disease course in patients with head and neck tumours. Head of the research topic: junior researcher Justina Bekampytė / consultant Prof. Rasa Ugenskienė
  • miR-200c and miR-141 associations with the disease course in patients with head and neck tumours. Head of the research topic: junior researcher Agnė Bartnykaitė / consultant Prof. Rasa Ugenskienė
  • Impact of SRSF1 gene polymorphisms on clinical and morphological features of breast cancer and the disease course in breast cancer patients. Head of the research topic: Dr. Aistė Savukaitytė
  • The role of genetic factors in cervical cancer patients. Head of the research topic: junior researcher Justina Bekampytė / consultant Prof. Rasa Ugenskienė
  • DNMT3A polymorphism analysis and the assessment of their effect on breast cancer phenotype and patient survival. Head of the research topic: Prof. Rasa Ugenskienė
  • FAS and FASL gene variant analysis and their effect on cervical cancer prognosis assessment. Head of the research topic: Rasa Ugenskienė
  • Analysis of XRCC1 gene polymorphisms in patients with myeloproliferative neoplasms. Temos vadovė j.m.d Roberta Vadeikienė / konsultantė prof. Rasa Ugenskienė
  • Analysis of prognostic factors in metastatic melanoma. Head of the research topic: Assoc. Prof. Sigita Liutkauskienė
  • Analysis of prognostic factors in inoperable ovarian cancer. Head of the research topic: Assoc. Prof. Sigita Liutkauskienė
  • Factors contributing to cardiac damage in patients undergoing haematopoietic stem cell transplantation. Head of the research topic: Dr. Domas Vaitiekus
  • Autologous haematopoietic stem cell transplantation in lymphoma patients. Head of the research topic: Dr. Rūta Dambrauskienė
  • Assessment, treatment and outcome of frailty in non-transplant myeloma patients. Head of the research topic: Lect. Milda Rudžianskienė
  • Impact of HOTAIR polymorphisms of long non-coding RNA molecule on clinical and morphological features of breast cancer and the disease course in breast cancer patients. Head of the research topic: Dr. Aistė Savukaitytė

> 20 researchers

7 projects under HORIZON 2020

Projects of the Institute of Oncology

  • HORIZON2020 H2020-EU.1.4.1.2. “INfraStructure in Proton International REsearch (INSPIRE)”
  • HORIZON2020 project projektas “A European Cancer Image Platform Linked to Biological and Health Data for Next-Generation Artificial Intelligence and Precision Medicine in Oncology (EurCanImage)”
  • HORIZON EUROPE HORIZON-MISS-2021-CANCER-02-01 “An innovative non-contact and harmless screening modality set to change the course of breast cancer detection and patient monitoring” (Thermobreast)

Joint Action projects under the EU4Health framework:

  • ID 101104587, Acronym ECHoS | Title “Establishing of Cancer Mission Hubs: Networks and Synergies” (Lithuanian: “Vėžio misijos centrų steigimas: tinklai ir sinergija”)
  • ID 101075284, Acronym CraNE | Title “Network of Comprehensive Cancer Centres: Preparatory activities on creation of National Comprehensive Cancer Centres and EU Networking” (Lithuanian: “Kompleksinių vėžio centrų tinklas: parengiamoji veikla kuriant nacionalinius kompleksinius vėžio centrus ir ES tinklų kūrimas”
  • ID 101075328, Acronym JANE | Title “Joint Action on Networks of Expertise” (Lithuanian: “Bendri veiksmai dėl kompetencijos tinklų”)
  • Joint Action on strengthening eHealth including telemedicine and telemonitoring for health care systems for cancer prevention and care – eCAN
  • Project “Gene expression analysis using the next-generation gene sequencing and the analysis of post-translational protein modifications for the identification of anticancer action mechanisms of aspirin” (funded by the Research Council of Lithuania, Funding Agreement No. S-MIP-17-56)
  • Project “The model of provision of healthcare services to cancer patients in the cases of pandemics” (funded by the Research Council of Lithuania)
  • Project “Digital phenotyping for monitoring of cancer patients during the COVID-19 pandemic” (funded by the Research Council of Lithuania, No. 01.2.2.-LMT-K-718-05-0085)
  • Interinstitutional project by the LSMU and KTU: Project No.: PP2022/58/4. Project implementation period: 01/04/2022 – 31/12/2022. “Development of a Radiomic and Dosiomic Based Prognostic Model of Head and Neck Cancer Using Artificial Intelligence Methods (RADIC)”

The Institute joined the CERN Baltic Group uniting the universities of the Baltic Countries in 2022.

The CERN LT Consortium is an agreement signed on 22 June 2022 between Vilnius University, Kaunas University of Technology and Lithuanian University of Health Sciences to bring together Lithuanian researchers from different research fields and disciplines to conduct research on CERN topics of interest and facilitate them in joining the ongoing and planned activities at the CERN.

The CERN-LT Consortium Board includes the Radiobiology Research Group represented by Prof. Dr. Elona Juozaityte.

R&D projects related to CERN activities:

  • CERN-LSMU project “Molecular mechanisms determining the breast cancer resistance to radiotherapy and analysis of the influence of radiosensitizers” (No. PRM19-114/CERN-LSMU-2019-1)
  • R&D project related to CERN activities “Exploration of the radiosensitizing phytochemicals and analysis of their influence on the mechanisms of apoptosis of breast cancer cells in vitro” (No. CERN-LSMU -2021-4/202-PRO-0092)
  • Project “Optimisation of flow management of patients with suspected oncological disease in medical institutions providing specialised oncological care” (project No. 08.4.2-ESFA-V-619-02-0001, funded by the EU structural funds)
  • Project “Improving the quality of healthcare by developing integrated healthcare standards for the main causes of death in Lithuania” (funded by the EU structural funds)
  • 82313 P-DNR-21-37_Healthcare Service Provision Model (S ) 2021 05 10-2021 12 31
  • Project “LSMU activities for the improvement of doctors’ competences and qualifications (LSMU-GYD-KOM)” (No. 09.4.2-ESFA-V-715-05-0001)
  • Project “Development of a model of entrustable professional activities (EPAs) for medical residents” ESFA_LSMU-GYD-KOM_PRM18-134 (S18119)

Project of funded by the Research Fund of Kaunas Clinics “Radiomics-based non-invasive assessment of sentinel lymph node involvement in early laryngeal cancer” 01/2022 – 05/2023

Projects of the Ministry of Health: “Improving the quality of healthcare by developing integrated healthcare standards for the main causes of death in Lithuania”

Publications of the Institute of Oncology

Major articles in the Web of Science DB-referenced publications with an Impact Factor (recent 5 years):

1. Bartnykaitė, Agnė; Savukaitytė, Aistė; Bekampytė, Justina; Ugenskienė, Rasa; Laukaitienė, Jolanta; Korobeinikova, Erika; Gudaitienė, Jurgita; Juozaitytė, Elona. The Role of Matrix Metalloproteinase Single-Nucleotide Polymorphisms in the Clinicopathological Properties of Breast Cancer // Biomedicines. Basel : MDPI. ISSN 2227-9059, 2022, vol. 10, no. 8, p. 1-13. doi:10.3390/biomedicines10081891. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9405670/ . Science Citation Index Expanded (Web of Science); PubMed. [S1] [Science field: M001] [Impact Factor: 4.757, Aggregate Impact Factor: 5.644, Quartile: Q2 (2021. InCites JCR SCIE)]

2. Bekampytė, Justina; Savukaitytė, Aistė; Bartnykaitė, Agnė; Ugenskienė, Rasa; Žilienė, Eglė; Inčiūra, Arturas; Juozaitytė, Elona. TIRAP Rs8177376, Rs611953, Rs3802814, and Rs8177374 Polymorphisms and Their Association with Cervical Cancer Phenotype and Prognosis // Genes. Basel : MDPI. ISSN 2073-4425, 2022, vol. 13, no. 8, p. 1-11. doi:10.3390/genes13081365. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9407394/ . Science Citation Index Expanded (Web of Science); PubMed. [S1] [Science field: M001, N010] [Impact Factor: 4.141, Aggregate Impact Factor: 4.683, Quartile: Q2 (2021. InCites JCR SCIE)]

3. De Vitte, Kristina; Kerzienė, Sigita; Klementavičiūtė, Jolita; De Vitte, Marius; Dilbienė, Vaida; Ugenskienė, Rasa; Bartkienė, Elena; Stankevičius, Rolandas. Effect of restricted grazing or feeding with total mix ration environments on the properties of milk quantity and quality from dairy cows of different genotypes // Žemdirbystė = Agriculture. Kėdainiai : The Lithuanian Institute of Agriculture. ISSN 1392-3196, 2022, vol. 109, no. 2, p. 185-190. doi:10.13080/za.2022.109.024. Available from: https://doi.org/10.13080/z-a.2022.109.024 . Science Citation Index Expanded (Web of Science); Scopus; CAB Abstracts; Index Copernicus; VINITI. [S1] [Science field: A003] [Impact Factor: 1.281, Aggregate Impact Factor: 3.587, Quartile: Q3 (2021. InCites JCR SCIE)]

4. Kudrevičius, Linas; Jaselskė, Evelina; Adliene, Diana; Rudžianskas, Viktoras; Radžiūnas, Andrius; Tamašauskas, Arimantas. Application of 3D Gel Dosimetry as a Quality Assurance Tool in Functional Leksell Gamma Knife Radiosurgery // Gels. Basel : MDPI. ISSN 2310-2861, 2022, vol. 8, no. 2, p. 1-15. doi:10.3390/gels8020069. Science Citation Index Expanded (Web of Science). [S1] [Science field: M001, N002] [Impact Factor: 4.432, Aggregate Impact Factor: 5.162, Quartile: Q1 (2021. InCites JCR SCIE)]

5. Milonas, Daimantas; Laenen, Annouschka L; Venclovas, Žilvinas; Jaruševičius, Laimonas; Devos, Gaëtan; Joniau, Steven. Benefits of early salvage therapy on oncological outcomes in high-risk prostate cancer with persistent PSA after radical prostatectomy // Clinical and Translational Oncology. Cham : Springer International Publishing. ISSN 1699-048X, 2022, vol. 24, no. 2, p. 371-378. doi:10.1007/s12094-021-02700-y. Available from: https://pubmed.ncbi.nlm.nih.gov/34453699/ . Science Citation Index Expanded (Web of Science); PubMed. [S1] [Science field: M001] [Impact Factor: 3.34, Aggregate Impact Factor: 6.351, Quartile: Q3 (2021. InCites JCR SCIE)]

6. Vadeikienė, Roberta; Kurgonaitė, Monika; Dambrauskienė, Rūta; Ugenskienė, Rasa; Gerbutavičius, Rolandas; Juozaitytė, Elona. Genetic factors that may affect the risk of developing thrombosis in patients with myeloproliferative disorders // Archives of medical science. Poznan : Termedia Publishing House Ltd. ISSN 1734-1922, 2021, vol. 00, no. 00, p. 1-42. doi:10.5114/aoms/140399. Available from: https://doi.org/10.5114/aoms/140399 . Science Citation Index Expanded (Web of Science). [S1] [Science field: M001, N010] [Impact Factor: 3.707, Aggregate Impact Factor: 8.28, Quartile: Q2 (2021. InCites JCR SCIE)]

7. Bartnykaitė, Agnė; Savukaitytė, Aistė; Ugenskienė, Rasa; Daukšaitė, Monika; Korobeinikova, Erika; Gudaitienė, Jurgita; Juozaitytė, Elona. Associations of MDM2 and MDM4 Polymorphisms with Early-Stage Breast Cancer // Journal of Clinical Medicine. Basel : MDPI. ISSN 2077-0383, 2021, vol. 10, no. 4, p. 1-11. doi:10.3390/jcm10040866. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7922970/ . Science Citation Index Expanded (Web of Science); PubMed. [S1] [Science field: M001] [Impact Factor: 4.964, Aggregate Impact Factor: 8.28, Quartile: Q2 (2021. InCites JCR SCIE)]

8. Bekampytė, Justina; Bartnykaitė, Agnė; Savukaitytė, Aistė; Ugenskienė, Rasa; Korobeinikova, Erika; Gudaitienė, Jurgita; Juozaitytė, Elona. The Investigation of Associations between TP53 rs1042522, BBC3 rs2032809, CCND1 rs9344, EGFR rs2227983 Polymorphisms and Breast Cancer Phenotype and Prognosis // Diagnostics. Basel : MDPI AG. ISSN 2075-4418, 2021, vol. 11, no. 8, p. 1-14. doi:10.3390/diagnostics11081419. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8393676/ . Science Citation Index Expanded (Web of Science); PubMed. [S1] [Science field: M001] [Impact Factor: 3.992, Aggregate Impact Factor: 8.28, Quartile: Q2 (2021. InCites JCR SCIE)]

9. Golubickaitė, Ieva; Ugenskienė, Rasa; Korobeinikova, Erika; Gudaitienė, Jurgita; Vaitiekus, Domas; Poškienė, Lina; Juozaitytė, Elona. The impact of mitochondria related POLG and TFAM variants on breast cancer pathomorphological characteristics and patient outcomes // Biomarkers. Oxon : Taylor & Francis. ISSN 1354-750X, 2021 vol. 26, no. 4, p. 343-353. doi:10.1080/1354750X.2021.1900397. Available from: https://pubmed.ncbi.nlm.nih.gov/33715547/ . Science Citation Index Expanded (Web of Science); PubMed. [S1] [Science field: M001] [Impact Factor: 2.663, Aggregate Impact Factor: 5.094, Quartile: Q3 (2021. InCites JCR SCIE)]

10. Golubickaitė, Ieva; Ugenskienė, Rasa; Žilienė, Eglė; Beniušytė, Jurgita; Inčiūra, Arturas; Poškienė, Lina; Juozaitytė, Elona. POLG gene variants in cervical cancer patients and their associations with clinical and pathomorphological tumor characteristics // Journal of Clinical Medicine. Basel : MDPI. ISSN 2077-0383, 2021, vol. 10, no. 9 doi:10.3390/jcm10091838. Available from: https://doi.org/10.3390/jcm10091838 . Science Citation Index Expanded (Web of Science); PubMed. [S1] [Science field: M001] [Impact Factor: 4.964, Aggregate Impact Factor: 8.28, Quartile: Q2 (2021. InCites JCR SCIE)]

11. Korobeinikova, Erika; Ugenskienė, Rasa; Insodaitė, Rūta; Rudžianskas, Viktoras; Gudaitienė, Jurgita; Juozaitytė, Elona. The role of functional polymorphisms in oxidative stress-related genes on early-stage breast cancer survival // International journal of biological markers. London : SAGE Publishing. ISSN 0393-6155, 2021, vol. 36, no. 2, p. 14-21. doi:0.1177/17246008211011177. Available from: https://pubmed.ncbi.nlm.nih.gov/33885357/ . Science Citation Index Expanded (Web of Science); PubMed; Biological Abstracts; BIOSIS Previews. [S1] [Science field: M001] [Impact Factor: 3.248, Aggregate Impact Factor: 6.017, Quartile: Q3 (2021. InCites JCR SCIE)]

12. Savukaitytė, Aistė; Gudoitytė, Greta; Bartnykaitė, Agnė; Ugenskienė, Rasa; Juozaitytė, Elona. siRNA Knockdown of REDD1 Facilitates Aspirin-Mediated Dephosphorylation of mTORC1 Target 4E-BP1 in MDA-MB-468 Human Breast Cancer Cell Line // Cancer management and research. Auckland : Dove Medical Press. ISSN 1179-1322, 2021, vol. 13, p. 1123-1133. doi:10.2147/CMAR.S264414. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7872862/ . Science Citation Index Expanded (Web of Science); MEDLINE. [S1] [Science field: M001] [Impact Factor: 3.602, Aggregate Impact Factor: 6.351, Quartile: Q3 (2021. InCites JCR SCIE)

13. Vaitiekus, Domas; Muckienė, Gintarė; Vaitiekienė, Audronė; Sereikaitė, Liveta; Inčiūraitė, Rūta; Insodaitė, Rūta; Čepulienė, Daiva; Kupčinskas, Juozas; Ugenskienė, Rasa; Jurkevičius, Renaldas; Juozaitytė, Elona. HFE Gene Variants’ Impact on Anthracycline-Based ChemotherapyInduced Subclinical Cardiotoxicity : original paper // Cardiovascular Toxicology. Totowa : Humana Press. ISSN 1530-7905, 2021, vol. 21, no. 1, p. 59-66. doi:10.1007/s12012-020-09595-1. Available from: https://pubmed.ncbi.nlm.nih.gov/32748118/ . Science Citation Index Expanded (Web of Science); MEDLINE. [S1] [Science field: M001] [Impact Factor: 2.755, Aggregate Impact Factor: 5.249, Quartile: Q3 (2021. InCites JCR SCIE)]

14. Grina, Donatas; Karpavičiūtė, Justina; Minkutė, Rima; Briedis, Vitalis. Impact of hospitalization on potentially inappropriate prescribing: a cross sectional study in an acute geriatric hospital in Lithuania : research article // International journal of clinical pharmacy. Dordrecht : Springer. ISSN 2210-7703, 2020, vol. 42, no. 3, p. 903-910. doi:10.1007/s11096-020-01035-y. Available from: https://pubmed.ncbi.nlm.nih.gov/32323108/ . Science Citation Index Expanded (Web of Science); MEDLINE. [S1] [Science field: M003, M005] [Impact Factor: 2.054, Aggregate Impact Factor: 4.307, Quartile: Q4 (2020. InCites JCR SCIE)]

15. Korobeinikova, Erika; Ugenskienė, Rasa; Insodaitė, Rūta; Rudžianskas, Viktoras; Jaselskė, Evelina; Poškienė, Lina; Juozaitytė, Elona. Association of angiogenesis and inflammationrelated gene functional polymorphisms with early-stage breast cancer prognosis // Oncology letters. Athens : Spandidos publ LTD. ISSN 1792-1074, 2020, vol. 19, no. 6, p. 3687-3700. doi:10.3892/ol.2020.11521. Available from: https://pubmed.ncbi.nlm.nih.gov/32391092/ . Science Citation Index Expanded (Web of Science); MEDLINE. [S1] [Science field: M001] [Impact Factor: 2.967, Aggregate Impact Factor: 6.246, Quartile: Q4 (2020. InCites JCR SCIE)]

16. Paužas, Henrikas; Gyvytė, Ugnė; Latkauskas, Tadas; Kairevičė, Laura; Lizdenis, Paulius; Švagždys, Saulius; Birgiolaitė, Erika; Kuliavienė, Irma; Kupčinskas, Juozas; Tamelis, Algimantas. The Role of VEGFA, COX2, HUR and CUGBP2 in predicting the response to neoadjuvant therapy in rectal cancer patients // Medicina. Kaunas ; Basel : LSMU ; MDPI. ISSN 1010-660X, 2020, vol. 56, no. 4, p. 1-12. doi:10.3390/medicina56040192. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7230171/ . Science Citation Index Expanded (Web of Science); PubMed. [S1] [Science field: M001] [Impact Factor: 2.43, Aggregate Impact Factor: 5.181, Quartile: Q2 (2020. InCites JCR SCIE)]

17. Socha, Joanna; Kairevičė, Laura; Kępka, Lucyna; Michalski, Wojciech; Spałek, Mateusz; Paciorek, Karol; Bujko, Krzysztof. Should Short-course Neoadjuvant Radiotherapy Be Applied for Low-lying Rectal Cancer? A Systematic Review and Meta-analysis of the Randomized Trials // International journal of radiation oncology, biology, physics. New York, NY : Elsevier. ISSN 0360-3016, 2020, vol. 108, no. 5, p. 1257-1264. doi:10.1016/j.ijrobp.2020.06.077. Available from: https://pubmed.ncbi.nlm.nih.gov/32634546/ . Science Citation Index Expanded (Web of Science); MEDLINE. [S1] [Science field: M001] [Impact Factor: 7.038, Aggregate Impact Factor: 5.105, Quartile: Q1 (2020. InCites JCR SCIE)]

18.  Vaitiekus, Domas; Muckienė, Gintarė; Vaitiekienė, Audronė; Mačiulienė, Dainora; Vaičiulienė, Dovilė; Ambrazevičiūtė, Gretė; Sereikaitė, Liveta; Verikas, Dovydas; Jurkevičius, Renaldas; Juozaitytė, Elona. Impact of arterial hypertension on doxorubicin-based chemotherapy-induced subclinical cardiac damage in breast cancer patients // Cardiovascular Toxicology. Totowa : Humana Press. ISSN 1530-7905, 2020, vol. 20, no. 3, p. 321-327. doi:10.1007/s12012-019-09556-3. Available from: https://pubmed.ncbi.nlm.nih.gov/31782105/ . Science Citation Index Expanded (Web of Science); MEDLINE. [S1] [Science field: M001] [Impact Factor: 3.231, Aggregate Impact Factor: 4.848, Quartile: Q2 (2020. InCites JCR SCIE)]

19. Aljurf, Mahmoud; Weisdorf, Daniel; Alfraih, Feras; Szer, Jeff; Müller, Carlheinz; Confer, Dennis; Hashmi, Shahrukh; Kröger, Nicolaus; Shaw, Bronwen E; Greinix, Hildegard; Kharfan-Dabaja, Mohamed A; Foeken, Lydia; Seber, Adriana; Ahmed, Syed; El-Jawahri, Areej; Al-Awwami, Moheeb; Atsuta, Yoshiko; Pasquini, Marcelo; Hanbali, Amr; Alzahrani, Hazzaa; Okamoto, Shinichiro; Gluckman, Eliane; Mohty, Mohamad; Kodera, Yoshihisa; Horowitz, Mary; Niederwieser, Dietger Walter; El Fakih, Riad. “Worldwide Network for Blood & Marrow Transplantation (WBMT) special article, challenges facing emerging alternate donor registries” // Bone Marrow Transplantation. London : Nature Publishing Group. ISSN 0268-3369, 2019, vol. 54, no. 8, p. 1179-1188. doi:10.1038/s41409-019-0476-6. [S1] [Science field: M001] [Impact Factor: 4.725, Aggregate Impact Factor: 4.255, Quartile: Q1 (2019. InCites JCR SCIE)]

20. Cohen, Ezra E W; Soulières, Denis; Le Tourneau, Christophe; Dinis, José; Licitra, Lisa; Ahn, Myung-Ju; Soria, Ainara; Machiels, Jean-Pascal; Mach, Nicolas; Mehra, Ranee; Burtness, Barbara; Zhang, Pingye; Cheng, Jonathan; Swaby, Ramona F; Harrington, Kevin J; Aleknavičius, Eduardas (investigator); Inčiūra, Arturas (investigator). Pembrolizumab versus methotrexate, docetaxel, or cetuximab for recurrent or metastatic head-and-neck squamous cell carcinoma (KEYNOTE-040): a randomised, open-label, phase 3 study // Lancet. New York : Elsevier Science Inc. ISSN 0140-6736, 2019, vol. 393, no. 10167, p. 156-167. doi:10.1016/S0140-6736(18)31999-8. Available from: https://pubmed.ncbi.nlm.nih.gov/30509740/ . Science Citation Index Expanded (Web of Science); MEDLINE; Scopus. [S1] [Science field: M001] [Impact Factor: 60.392, Aggregate Impact Factor: 4.386, Quartile: Q1 (2019. InCites JCR SCIE)]

21. Vaitiekienė, Audronė; Vaitiekus, Domas; Urbonaitė, Laura; Jankauskas, Antanas; Portačenko, Justina; Lapinskas, Tomas; Benetis, Rimantas; Siudikas, Adakrius; Veikutienė, Audronė; Poškienė, Lina; Kavoliūnienė, Aušra; Jančiauskienė, Rasa; Jaruševičius, Laimonas; Juozaitytė, Elona; Žaliūnas, Remigijus; Ereminienė, Eglė. Multidisciplinary approach to rare primary cardiac sarcoma: a case report and review : case report // BMC cancer. London : BioMed Central. ISSN 1471-2407, 2019, vol. 19, no. 1, p. 1-6. doi:10.1186/s12885-019-5705-2. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6544955/ . Science Citation Index Expanded (Web of Science); MEDLINE; CABI Global Health; Scopus. [S1] [Science field: M001] [Impact Factor: 3.15, Aggregate Impact Factor: 4.837, Quartile: Q3 (2019. InCites JCR SCIE)]

22.  Žoštautienė, Indrė; Skrodenienė, Erika; Vitkauskienė, Astra; Žvinienė, Kristina; Mickevičius, Antanas; Gerbutavičius, Rolandas; Gerbutavičienė, Rima Jūratė; Kiudelis, Mindaugas. Coagulation System Disorders and Thrombosis Prophylaxis During Laparoscopic Fundoplications // Surgical laparoscopy, endoscopy, and percutaneous techniques. Hagerstown : Lippincott Williams & Wilkins. ISSN 1530-4515, 2019, vol. 29, no. 6, p. 433-440. doi:10.1097/SLE.0000000000000709. Available from: https://pubmed.ncbi.nlm.nih.gov/31517745/ . Science Citation Index Expanded (Web of Science); MEDLINE. [S1] [Science field: M001] [Impact Factor: 1.382, Aggregate Impact Factor: 2.553, Quartile: Q3 (2019. InCites JCR SCIE)]

23. Adlienė, Diana; Jaselskė, Evelina; Rudžianskas, Viktoras; Šeperiene, Neringa. First approach to ionizing radiation based 3D printing: fabrication of free standing dose gels using high energy gamma photons // Nuclear instruments and methods in physics research, Section B: Beam interactions with materials and atoms : 19th International Conference on Radiation Effects in Insulators (REI), JUL 02-07, 2017, France. Amsterdam : Elsevier. ISSN 0168-583X, 2018, vol. 435, p. 246-250. doi:10.1016/j.nimb.2018.01.033. Available from: https://doi.org/10.1016/j.nimb.2018.01.033 . [S1] [Science field: M001] [Impact Factor: 1.21, Aggregate Impact Factor: 2.497, Quartile: Q3 (2018. InCites JCR SCIE)]

24.  Breugom, Anne J; Bastiaannet, Esther; Boelens, Petra G; Van Eycken, Elisabeth; Iversen, Lene H; Martling, Anna; Johansson, Robert; Evans, Tim; Lawton, Sarah; O’Brien, Katie M; Ortiz, Héctor; Jančiauskienė, Rasa; Dekkers, Olaf M; Rutten, Harm JT; Liefers, Gerrit-Jan; Lemmens, Valery EPP; van de Velde, Cornelis JH. Oncologic treatment strategies and relative survival of patients with stage I-III rectal cancer – A EURECCA international comparison between the Netherlands, Belgium, Denmark, Sweden, England, Ireland, Spain, and Lithuania // European journal of surgical oncology – EJSO. Amsterdam : Elsevier. ISSN 0748-7983, 2018, vol. 44, no. 9, p. 1336-1343. doi:10.1016/j.ejso.2018.05.025. Available from: https://pubmed.ncbi.nlm.nih.gov/29960770/ . Science Citation Index Expanded (Web of Science); MEDLINE; Scopus. [S1] [Science field: M001] [Impact Factor: 3.379, Aggregate Impact Factor: 3.527, Quartile: Q1 (2018. InCites JCR SCIE)]

25. Būdienė, Brigita; Liutkevičienė, Rasa; Gustienė, Olivija; Ugenskienė, Rasa; Laukaitienė, Danguolė; Savukaitytė, Aistė; Vilkevičiūtė, Alvita; Steponavičiūtė, Rasa; Petrikienė, Aurelija; Žaliūnienė, Dalia. The Association of matrix metalloproteinases polymorphisms and interleukins in advanced age-related macular degeneration // Ophthalmic genetics. Philadelphia : Taylor & Francis. ISSN 1381-6810, 2018, vol. 39, no. 4, p. 463-472. doi:10.1080/13816810.2018.1484928. Available from: https://pubmed.ncbi.nlm.nih.gov/29947568/ . Science Citation Index Expanded (Web of Science); MEDLINE. [S1] [Science field: M001] [Impact Factor: 1.285, Aggregate Impact Factor: 3.246, Quartile: Q4 (2018. InCites JCR SCIE)]

26. Liutkauskienė, Sigita; Grižas, Saulius; Jurėnienė, Kristina; Šuipytė, Jorūnė; Statnickaitė, Akvilė; Juozaitytė, Elona. Retrospective analysis of the impact of anthracycline dose reduction and chemotherapy delays on the outcomes of early breast cancer molecular subtypes // BMC cancer. London : BioMed Central. ISSN 1471-2407, 2018, vol. 18, no. 1, p. 1-9. doi:10.1186/s12885-018-4365-y. Available from: https://pubmed.ncbi.nlm.nih.gov/29678165/ . Science Citation Index Expanded (Web of Science); MEDLINE; CABI Global Health; Scopus. [S1] [Science field: M001] [Impact Factor: 2.933, Aggregate Impact Factor: 4.497, Quartile: Q3 (2018. InCites JCR SCIE)]

27. Rudžianskas, Viktoras; Korobeinikova, Erika; Rudžianskienė, Milda; Jaselskė, Evelina; Adlienė, Diana; Šedienė, Severina; Kulakienė, Ilona; Padervinskis, Evaldas; Jurkienė, Nemira; Juozaitytė, Elona. Use of 18F-FDG PET/CT imaging for radiotherapy target volume delineation after induction chemotherapy and for prognosis of locally advanced squamous cell carcinoma of the head and neck // Medicina. Basel : MDPI. ISSN 1010-660X, 2018, vol. 54, no. 6, p. 1-18. doi:10.3390/medicina54060107. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6306774/ . Science Citation Index Expanded (Web of Science); MEDLINE. [S1] [Science field: M001] [Impact Factor: 1.467, Aggregate Impact Factor: 4.542, Quartile: Q3 (2018. InCites JCR SCIE)]

28. Šedienė, Severina; Kulakienė, Ilona; Rudžianskas, Viktoras; Ambrazienė, Rita. The Role of 18-fluoro-2-deoxy-glucose positron emission tomography/computed tomography as response and prognosis predictive factor of concurrent chemoradiotherapy after induction chemotherapy in head and neck squamous cell carcinoma: A prospective study // Medicina. Basel : MDPI. ISSN 1010-660X, 2018, vol. 54, no. 2, p. 1-13. doi:10.3390/medicina54020031. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6037264/ . Science Citation Index Expanded (Web of Science); MEDLINE; IndexCopernicus; Scopus; DOAJ. [S1] [Science field: M001] [Impact Factor: 1.467, Aggregate Impact Factor: 4.542, Quartile: Q3 (2018. InCites JCR SCIE)]

Institute of Oncology
+370 37 326 645 onkologijos.klinika@kaunoklinikos.lt
Eivenių g. 2, Kaunas
Prof. Elona Juozaitytė
Head of the Institute of Oncology
+370 37 326 726 elona.juozaityte@lsmu.lt
All contacts
Faculty of Medicine
Faculty of Odontology
Faculty of Pharmacy
Faculty of Public Health
Faculty of Nursing
Faculty of Veterinary Medicine
Faculty of Animal Science